Smith & Nephew

• MAKO Surgical Battles Back into the Ring

  By Erik Eason - March 29, 2013 | Tickers: ISRG, MAKO, SNN, SYK, ZMH

  MAKO Surgical’s (NASDAQ: MAKO) fourth-quarter results answered the mail on all three of the Market’s concerns: Strong sales of RIO surgical robots; Record number of surgical procedures; Pricing holds firm while the expense ratio continues to decline. It is a prize fighter back in the ring, yet the Market yawned. So what is it this time?

  In a nutshell: “Show me.” The market wants to see a sustained more »

• How to Play UK-based Pharma Stocks

  By Zain Abbas - January 30, 2013 | Tickers: AZN, GSK, HKMPF, SHPG, SNN

  A number of UK pharmaceutical companies trade on the NYSE and NASDAQ. However, in the presence of companies like Johnson & Johnson, local investors hardly pay any attention to these companies (which is shown by their low trading volumes). GlaxoSmithKline (NYSE: GSK) seems to be the only exception. In this article, I have briefly touched upon the UK healthcare sector and ranked them according to my preference.

  I am a big more »

• Will MAKO Get Back on its Feet?

  By Erik Eason - January 28, 2013 | Tickers: ISRG, MAKO, SNN, SYK, ZMH

  MAKO Surgical (NASDAQ: MAKO) recently pre-released sales quantities to assuage the Market's anxiety, after a rough year of poor sales, over whether it would make its 2012 targets. The sales of RIO surgical robots (15 RIOs) was spot on the middle of their forecast range, and the number of procedures surged back up to an all-time high (2,904), which returned them close to their average number of procedures more »

• Top-Rated Dividend Stocks in the Health Care Industry

  By Aubrey Tabuga - January 16, 2013 | Tickers: CMN, CHE, NVO, SNN, SPAN

  There are good reasons why the health care industry is an investor’s haven in 2013. Rapidly ageing population of developed countries and robust economic growth of developing economies are pushing both health care expenditures and innovations to new heights.  I looked at the sector's top-rated stocks, and picked those with impressive dividend record and high potential for growth. These are Novo Nordisk  (NYSE: NVO), Smith & Nephew (NYSE: SNNmore »)

• Earnings Report : MAKO Makes the Grade

  By Erik Eason - November 8, 2012 | Tickers: ISRG, MAKO, SNN, SYK, ZMH

  MAKO Surgical's (NASDAQ: MAKO) 3rd quarter earnings report came out on Wednesday and it is, along with the subsequent conference call, chock full of valuable and detailed information. That's something I prize in CEO Maurice Ferré: He and his management team know what's important to MAKO's future, and they share a rich bounty of information on those topics.

  As a prelude to this earnings announcement, I more »

• It's Showtime for MAKO

  By Erik Eason - October 25, 2012 | Tickers: ISRG, MAKO, SNN, SYK, ZMH |

  MAKO Surgical's (NASDAQ: MAKO) earnings report is approaching, and much is riding on the results. Many eyes will read the report, and many ears will listen to the conference call. Let's be prepared so that we, as individual retail investors, can determine for ourselves whether MAKO is successfully navigating the difficult task of bringing mainstream customers onto their sales roster.

  As each earnings season approaches I like to more »

• Surgical Robot Wars

  By Erik Eason - August 24, 2012 | Tickers: ISRG, MAKO, SNN, SYK, ZMH |

  The stakes are getting higher. During the most recent MAKO Surgical (NASDAQ: MAKO) conference call, CEO Maurice Ferré noted that they have “gained increasing attention from competitors.” So the heat is officially on ... and this at a time when MAKO's sales have stumbled.

  Who will come out on top of the struggle for robotic supremacy? That is the $64 question facing investors, and we have a lot more than more »

• Medical Device Makers' Sad Tale

  By Tony Daltorio - May 21, 2012 | Tickers: BSX, MDT, SNN, ZMH

  Medical cost inflation is an everyday fact of life for most Americans. So you would think most companies in the medical field are raking in the money. But not so for the sprawling $300 billion medical device industry...an industry that is becoming ever more important in improving the quality of life and prolonging it for people around the globe. 

  Profit margins for medical device manufacturers continue to shrink under more »

• 6 Undervalued Stocks That Could Take Off in 2012

  By Robert Fisher - January 28, 2012 | Tickers: APH, BDX, LH, RL, RCI, SNN

  With the uneven recovery taking place on Wall Street, investors are being forced to spend extra time researching companies and the prospect of their success. While a number of well-known companies have gotten off to a great start in 2012, there are still plenty of businesses that have yet to be discovered. Among these, six undervalued stocks with strong potential are Becton, Dickinson and Company (NYSE: BDX), Rogers Communication Inc more »